75 results
Page 3 of 4
20-F
EX-2.3
bn6gnklzsly3us 5qxc
30 Mar 20
Annual report (foreign)
5:12pm
20-F
EX-12.2
wyir5m5
30 Mar 20
Annual report (foreign)
5:12pm
6-K
EX-99.1
sqwxyje8
10 Mar 20
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
9:17am
6-K
EX-99.1
a4e5a
27 Feb 20
Notice to Convene the Annual General Meeting of Genmab A/S
3:48pm
6-K
EX-99.1
hscnha
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
6-K
EX-99.1
a5a2cj7rpkut49gsgv
19 Dec 19
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
11:42am
424B4
kuvc8v94
19 Jul 19
Prospectus supplement with pricing info
12:00am
F-6EF
EX-4
hns f8y6re69p
18 Jul 19
Automatic registration for ADRs (foreign)
9:30am
F-1/A
07q61u5w1yiws4met
16 Jul 19
Registration statement (foreign) (amended)
8:05am
F-6 POS
EX-4
760c0pr
15 Jul 19
Automatic registration for ADRs (post-effective amendment, foreign)
5:01pm
F-1/A
4te8wtex4h2rf
9 Jul 19
Registration statement (foreign) (amended)
6:13am
F-1
0cc3ym zovd4s0jk
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.1
qaa8r abyyqv8oz
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.11
09m4sfbg57
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-4.1
fgznqmw5gh
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.6
gde4qtjeoefy
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.12
os32c 6ddlg
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.4
rhd4hi21mfa
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.8
24yg5wu s1
28 May 19
Registration statement (foreign)
4:27pm
F-1
EX-10.10
57zvi 7bbm4cbku
28 May 19
Registration statement (foreign)
4:27pm